Alberto Aparicio is an Assistant Professor in the Department of Bioethics and Health Humanities. He completed postdoctoral fellowships at the Global Observatory for Genome Editing at Harvard University and the Alexander von Humboldt Biological Resources Research Institute in Colombia. Dr. Aparicio holds a PhD in Science and Technology Studies from University College London and an MPhil in Technology Policy from Cambridge University. With experience in policy, academia, consultancy, and government, his research focuses on the governance of emerging biotechnology and the societal implications of bioscience, including evolving attitudes toward life and technoscience.

Dr. Ariel Zeleznikow-Johnston is a neuroscientist and Research Fellow at Monash University, Australia, specializing in the characterization of conscious experiences. He earned his PhD from the University of Melbourne in 2019, where he explored the impact of genetic and environmental factors on cognition. His research spans cognitive function across the lifespan and the subjective experience of color. Author of The Future Loves You: How and Why We Should Abolish Death, Dr. Zeleznikow-Johnston aims to advance medical infrastructure for brain preservation, potentially offering future revival for the dying by addressing the neurobiological and philosophical aspects of life and death.

Akshay Sanghavi is the founder of Stealth Longevity Research Biotech, a company focused on reversing biological age to cure chronic diseases. With over a decade of experience in epigenetics and gene regulation, Akshay has pioneered non-chemotherapy, immune-based cancer therapies and researched natural solutions to ameliorate aging-related biochemical declines. He also led innovative advancements in LED lighting technology as COO, where his team developed disruptive solutions that reduced parts by 70% and introduced the industry’s first lifetime warranty. Akshay’s work continues to push the boundaries of health and technology innovation.

Kamen Shoylev is a dual-qualified lawyer, practicing at both the Bulgarian and English Bars. As co-managing partner at New Balkans Law Office, he provides expert advice on corporate, commercial, regulatory, and IP law, focusing on cross-border issues between Bulgaria, the EU, and the UK. Kamen’s legal expertise spans corporate disputes, EU law, and intellectual property. With a keen interest in innovation and longevity, he integrates his knowledge of science, technology, and investment ethics into his work. Kamen holds a B.A. in Law from Cambridge University and is committed to advancing entrepreneurial and legal solutions globally.

Siim Land is an 8-time bestselling author, anthropologist, keynote speaker, and longevity advocate dedicated to maximizing healthy human lifespan. With over a decade of research into health, fitness, and mindset, he empowers high-performing individuals through his YouTube channel, blog, and online coaching. Combining a background in Cultural and Social Anthropology with a passion for human optimization, Siim Land delivers transformative insights into body-mind empowerment. His Amazon-bestselling books and rising video courses inspire audiences worldwide to thrive physically, mentally, and professionally.

Prof. Peter Lidsky is an expert in virology and genetics, with MS and PhD training from Moscow State University, focusing on virus-host interactions in Picornaviruses. He advanced his career at the University of Zurich, developing fluorescent imaging tools for Drosophila. At UCSF, Prof. Lidsky integrated his virology and genetics expertise, establishing a renowned research program. He is best known for developing the "pathogen control" hypothesis of aging, a pioneering framework that continues to shape his groundbreaking research on the intersection of aging, immunity, and pathogen dynamics.

Ethan Perlstein is a visionary scientist-entrepreneur dedicated to eradicating rare diseases. As Founder/CEO of Perlara PBC, the first biotech public benefit corporation, Ethan has pioneered healthspan-extending therapeutics and cures for rare metabolic disorders. He also leads Maggie's Pearl LLC, advancing precision medicines for ultra-rare conditions, and recently launched Curetopia, a groundbreaking DAO aiming to transform rare disease treatment through decentralized collaboration. With a PhD from Harvard and impactful roles at Princeton and the Reeve Foundation, Ethan blends innovation and leadership to redefine biotech’s role in global health.

Yuri Deigin is an entrepreneur, scientist, and biotech innovator with a deep focus on life sciences and longevity research. He is the co-founder and CEO of YouthBio Therapeutics, a company dedicated to developing cutting-edge gene therapies aimed at reversing aging processes at the cellular level. With a background in biotechnology, drug development, and artificial intelligence, Yuri has been at the forefront of translating scientific discoveries into practical solutions to combat age-related decline. His work is driven by a passion for advancing rejuvenation technologies to extend healthy human lifespan and improve quality of life.

Eleanor Sheekey is a dynamic scientist and communicator, blending cutting-edge research with engaging education. As a Postdoctoral Researcher at RIKEN, she explores skin aging and extracellular matrices, building on her PhD at the Cancer Research UK Cambridge Institute, where she studied p53 and cellular senescence. Creator of the Sheekey Science Show YouTube channel, Eleanor simplifies complex science for almost 50K subscribers, covering topics like longevity and CRISPR. She’s also a guest lecturer and director of Sheekey Science Solutions. Passionate about knowledge-sharing, Eleanor’s work inspires curiosity and advances understanding in biomedicine.

Bernie Siegel is a physician and author with decades of experience in medical practice and patient care. He is the founder of Exceptional Cancer Patients (ECaP), a groundbreaking therapeutic approach emphasizing the mind-body connection and the power of self-healing. Bernie's work integrates traditional medicine with holistic practices, focusing on the role of love, hope, and personal empowerment in the healing process. His pioneering efforts have inspired millions through his books, lectures, and advocacy for compassionate, patient-centered care.

Jason Kelly is an entrepreneur and innovator with over a decade of experience in synthetic biology and biotechnology. He is the co-founder and CEO of Ginkgo Bioworks, a company pioneering the use of biological engineering to create sustainable solutions across industries. Jason's background is rooted in biological engineering and computational biology, with a focus on harnessing the power of living organisms to address global challenges. His work aims to revolutionize manufacturing, agriculture, and medicine by programming biology to create a more sustainable and healthier future.

Kazuma Kishida is the pioneering CEO of Dioseve, a groundbreaking biotech company revolutionizing infertility treatment by developing human eggs from iPS and ES cells. Under his leadership, Dioseve is at the forefront of creating new possibilities for couples struggling with infertility, aiming to redefine reproductive medicine. With a strong foundation in financial strategy from his tenure as a financial analyst at Houlihan Lokey, Kaz combines scientific innovation with business acumen to drive transformative advancements in biotech. Based in Tokyo, he is committed to delivering hope through science and innovation.

Dr. Keshav K. Singh, a globally recognized expert in longevity and mitochondrial science, is the founder and Chief Scientific Officer of Yuva Biosciences, a trailblazing biotech company focused on extending healthspan through mitochondrial innovation. As the Joy and Bill Harbert Endowed Chair at UAB and founding editor of Mitochondrion, Dr. Singh has authored over 100 publications and three books, earning honors like Stanford’s Top 2% Scientists and Newsweek’s Innovation Hero. A dynamic thought leader, he pioneers transformative research at the intersection of aging, health disparities, and mitochondrial genetics.

Paul Kiesow is a professor at Thomas Edison State University, where he teaches courses on news writing, communication, and literacy. He is an advocate for healthy aging with a personal commitment to life-extension practices. In the early 1990s, he began incorporating growth hormone releasers, such as arginine and ornithine, into his regimen to stimulate the pituitary gland's release of human growth hormone (HGH). Complementing this, Paul maintains a comprehensive "nutritional pantry" that includes a full range of antioxidants and high-potency vitamin and mineral supplements. His proactive approach has resulted in increased energy, improved muscle tone, and overall vitality, allowing him to enjoy life fully.

Sebastian Giwa is an entrepreneur and innovator with extensive experience in biotechnology and translational research. He is the founder of Sylvatica Biotech, a company at the forefront of developing advanced preservation technologies to enable organ banking and improve global access to transplantation. Sebastian's background spans cryobiology, tissue engineering, and regenerative medicine, with a focus on overcoming the challenges of long-term organ storage. His work aims to revolutionize healthcare by creating solutions that enhance the availability and efficiency of life-saving organ transplants worldwide.

Vladik Krupalnik, a visionary biotech entrepreneur, is the CEO, co-founder, and board member of RenewalBio, advancing groundbreaking innovations in regenerative medicine. With a diverse leadership background, including roles as COO of RenewalBio and CSO at Epeius Pharma, Vladik has spearheaded transformative work in cell and gene therapy, focusing on next-generation delivery systems for CNS therapies. As a co-inventor and board member of CatchMe Therapeutics, he drives cutting-edge solutions in oncology. His expertise spans bioinformatics, diagnostics, and translational research, making him a key strategist in biotech innovation.

Dr. Grant E. Fraser is a board-certified physician specializing in anti-aging and regenerative medicine, with over 25 years of experience in emergency medicine and a commitment to optimizing patient health. He is the founder of a telemedicine practice dedicated to improving healthspan, reversing health conditions, and slowing biological aging through personalized care. Dr. Fraser's medical background encompasses functional and integrative medicine, with a focus on preventive strategies and lifestyle optimization. His work aims to provide comprehensive, evidence-based approaches to enhance quality of life and promote longevity.

Jacob Peters is the Founder of Superpower.com, an audacious venture dedicated to transforming health and longevity. A serial entrepreneur, he co-founded Launch House, a dynamic startup ecosystem investing $25k-$250k in early-stage companies, and Commsor, a pioneering platform for community teams that raised $68M. Formerly a Data Scientist at J.P. Morgan, Jacob spearheaded innovation, winning accolades from CEO Jamie Dimon and presenting to 6,000+ attendees at a global symposium. Passionate about bold ideas, Jacob thrives at the intersection of technology, community, and human potential.

Matthew Osman is an entrepreneur and AI specialist with a diverse background in finance and law. He holds a degree in Philosophy, Politics, and Economics from the University of Oxford. He co-founded Legit.ai, a life science AI startup that utilized natural language processing to streamline research and development processes. Under his leadership, Legit.ai was acquired by Clora in 2020. Matthew's work focuses on integrating AI technologies across various industries to drive innovation and efficiency.